93 related articles for article (PubMed ID: 3105104)
1. The effects of modulation of prostanoid metabolism on the thoracic platelet accumulation induced by intravenous administration of collagen in the guinea-pig.
Butler KD; Shand RA; Wallis RB
Thromb Haemost; 1986 Dec; 56(3):263-7. PubMed ID: 3105104
[TBL] [Abstract][Full Text] [Related]
2. Intrathoracic platelet accumulation in the guinea-pig induced by intravenous administration of arachidonic acid--effect of cyclooxygenase and thromboxane synthetase inhibitors.
Barrett PA; Butler KD; Shand RA; Wallis RB
Thromb Haemost; 1986 Dec; 56(3):311-7. PubMed ID: 3105107
[TBL] [Abstract][Full Text] [Related]
3. Thromboxane A2 accounts for bronchoconstriction but not for platelet sequestration and microvascular albumin exchanges induced by fMLP in the guinea pig lung.
Bureau MF; De Clerck F; Lefort J; Arreto CD; Vargaftig BB
J Pharmacol Exp Ther; 1992 Feb; 260(2):832-40. PubMed ID: 1738127
[TBL] [Abstract][Full Text] [Related]
4. Influence of selective thromboxane synthetase blocker CGS-13080 on thromboxane and prostacyclin biosynthesis in whole blood: evidence for synthesis of prostacyclin by leukocytes from platelet-derived endoperoxides.
Mehta J; Mehta P; Lawson DL; Ostrowski N; Brigmon L
J Lab Clin Med; 1985 Sep; 106(3):246-52. PubMed ID: 3928780
[TBL] [Abstract][Full Text] [Related]
5. The effect of a thromboxane synthetase inhibitor, dazoxiben, and acetylsalicylic acid on platelet function and prostaglandin metabolism.
Dale J; Thaulow E; Myhre E; Parry J
Thromb Haemost; 1983 Oct; 50(3):703-6. PubMed ID: 6689091
[TBL] [Abstract][Full Text] [Related]
6. [Effects of berberine on platelet aggregation and plasma levels of TXB2 and 6-keto-PGF1 alpha in rats with reversible middle cerebral artery occlusion].
Wu JF; Liu TP
Yao Xue Xue Bao; 1995; 30(2):98-102. PubMed ID: 7785438
[TBL] [Abstract][Full Text] [Related]
7. Thromboxane-mediated activation of platelets and enhancement of platelet uptake onto collagen-coated glass or deendothelialized rabbit aorta. Comparative effects of a thromboxane antagonist (EPO45) and a thromboxane synthetase inhibitor (dazoxiben).
Menys VC; Davies JA
Lab Invest; 1984 Feb; 50(2):184-9. PubMed ID: 6546403
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of pulmonary accumulation of 51chromium-labelled rat platelets following intravenous application of ADP and collagen.
Klee A; Seiffge D
Thromb Haemost; 1991 May; 65(5):588-95. PubMed ID: 1871721
[TBL] [Abstract][Full Text] [Related]
9. In vivo redirection of prostaglandin endoperoxides into 6-keto PGF1 alpha formation by thromboxane synthetase inhibitors in the rat.
Maguire ED; Wallis RB
Thromb Res; 1983 Oct; 32(1):15-27. PubMed ID: 6689221
[TBL] [Abstract][Full Text] [Related]
10. Effects of Y-20811, a long-lasting thromboxane synthetase inhibitor, on thromboxane production and platelet function.
Mikashima H; Ochi H; Muramoto Y; Yasuda H; Tsuruta M; Maruyama Y
Thromb Res; 1986 Aug; 43(4):455-68. PubMed ID: 3094191
[TBL] [Abstract][Full Text] [Related]
11. Effects of thiofedrine on platelet aggregation, thromboxane B2 and 6-keto-PGF1 alpha in rats.
Qu YZ; Wang YE; Li XX
Methods Find Exp Clin Pharmacol; 1996 Jun; 18(5):297-300. PubMed ID: 8817463
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory effects of copper-aspirin complex on platelet aggregation.
Shen ZQ; Chen ZH; Ma GY; Wang DC; Wu WL; Liu WP; Yang YK; Xiong HZ
Zhongguo Yao Li Xue Bao; 1997 Jul; 18(4):358-62. PubMed ID: 10072923
[TBL] [Abstract][Full Text] [Related]
13. Platelet function in experimentally induced pancreatitis in the dog.
Jacobs RM; Murtaugh RJ; Fertel RH
Thromb Haemost; 1986 Apr; 55(2):197-200. PubMed ID: 3087002
[TBL] [Abstract][Full Text] [Related]
14. CGS 12970: a novel, long acting thromboxane synthetase inhibitor.
Ambler J; Butler KD; Ku EC; Maguire ED; Smith JR; Wallis RB
Br J Pharmacol; 1985 Oct; 86(2):497-504. PubMed ID: 2932197
[TBL] [Abstract][Full Text] [Related]
15. Effects of quercetin on platelet and reperfusion-induced arrhythmias in rats.
Xiao D; Gu ZL; Qian ZN
Zhongguo Yao Li Xue Bao; 1993 Nov; 14(6):505-8. PubMed ID: 8010047
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory effects of nimodipine on platelet aggregation and thrombosis.
Ren YJ; Lü AG; Zhang GQ; Jia DH
Zhongguo Yao Li Xue Bao; 1998 Mar; 19(2):158-60. PubMed ID: 10374642
[TBL] [Abstract][Full Text] [Related]
17. Effects of the selective inhibition of platelet thromboxane synthesis on the platelet-subendothelium interaction.
De La Cruz JP; Villalobos MA; Escalante R; Guerrero A; Arrebola MM; Sánchez de La Cuesta F
Br J Pharmacol; 2002 Dec; 137(7):1082-8. PubMed ID: 12429581
[TBL] [Abstract][Full Text] [Related]
18. Improvement of renal function with a selective thromboxane A2 synthetase inhibitor, DP-1904, in lupus nephritis.
Yoshida T; Kameda H; Ichikawa Y; Tojo T; Homma M
J Rheumatol; 1996 Oct; 23(10):1719-24. PubMed ID: 8895147
[TBL] [Abstract][Full Text] [Related]
19. Influence of mental stress on plasma level of prostaglandins, thromboxane B2 and on circulating platelet aggregates in man.
Mest HJ; Zehl U; Sziegoleit W; Taube C; Förster W
Prostaglandins Leukot Med; 1982 Jun; 8(6):553-63. PubMed ID: 6955811
[TBL] [Abstract][Full Text] [Related]
20. Mechanism of the therapeutic effect of anisodamine in disseminated intravascular coagulation: study of platelet adhesion and aggregation, malondialdehyde, thromboxane B2, 6-keto-prostaglandin F1 alpha, and microcirculation.
Zhang S; Chang AM; Li CF; Li ZJ; Yin ZJ; Zhao X; Liang SL
Exp Hematol; 1987 Jan; 15(1):65-71. PubMed ID: 3780890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
